# Corbus Pharmaceuticals Holdings, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/corbus-pharmaceuticals-holdings-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 17 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:51.162298+00:00 | | Last reviewed | 2026-10-17T04:46:51.162298+00:00 | ## Identity - Legal name: Corbus Pharmaceuticals Holdings, Inc. - Display name: Corbus Pharmaceuticals Holdings, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T15:33:02.334812+00:00 | | Completeness | 0.409 | | Record Quality | 0.844 | | Directors | 6 | | Committees | 2 | | Governance events | 13 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Anne Altmeyer, Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:5 - John K. Jenkins, M.D.: Director. Status: current. Independent: true. Since: 2018-01-01. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:6 - Rachelle S. Jacques: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member). claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:7 - Winston Kung: Director. Status: current. Independent: true. Since: 2024-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:8 - Yuri Maricich, MD: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:9 - Yuval Cohen, Ph.D.: Director. Status: current. Independent: false. Since: 2014-01-01. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:10 ## Committees - Audit (audit). Chair: Winston Kung. Members: Winston Kung (chair, current); Rachelle S. Jacques (member, current). committee_id=alpha:committee:corbus-pharmaceuticals-holdings-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Winston Kung (member, current). committee_id=alpha:committee:corbus-pharmaceuticals-holdings-inc:audit-chair ## Executive leadership - Dominic Smethurst: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:11 - Ian Hodgson, Ph.D.: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:12 - Sean Moran: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:13 - Yuval Cohen, Ph.D.: Chief Executive Officer, Director [CEO]. Status: current. claim_id=alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:14 ## Governance events - EXECUTIVE_APPOINTED: Dominic Smethurst executive of Corbus Pharmaceuticals Holdings, Inc., effective 2026-03-09. Effective: 2026-03-09. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:xndejg1lzrdaa - EXECUTIVE_APPOINTED: Ian Hodgson, Ph.D. executive of Corbus Pharmaceuticals Holdings, Inc., effective 2026-03-09. Effective: 2026-03-09. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:23w42pgd8sg3 - CFO_CHANGED: Sean Moran executive of Corbus Pharmaceuticals Holdings, Inc., effective 2026-03-09. Effective: 2026-03-09. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1nb8w9pbj60yb - CEO_CHANGED: Yuval Cohen, Ph.D. executive of Corbus Pharmaceuticals Holdings, Inc., effective 2026-03-09. Effective: 2026-03-09. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:q5zx50jbuar8 - DIRECTOR_APPOINTED: Winston Kung seat on Corbus Pharmaceuticals Holdings, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1l36690xtm9em - COMMITTEE_CREATED: Audit · Chair committee of Corbus Pharmaceuticals Holdings, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:19mx8qc1r7vaqu - COMMITTEE_MEMBER_ADDED: Winston Kung member of Audit · Chair, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:151w3zn1bi96b1 - DIRECTOR_APPOINTED: Yuri Maricich, MD seat on Corbus Pharmaceuticals Holdings, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1wr1byc1aixgnw - DIRECTOR_APPOINTED: Anne Altmeyer, Ph.D. seat on Corbus Pharmaceuticals Holdings, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:xs1wthbajopl - DIRECTOR_APPOINTED: Rachelle S. Jacques seat on Corbus Pharmaceuticals Holdings, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:8p01yl6xap67 - COMMITTEE_MEMBER_ADDED: Rachelle S. Jacques member of Audit, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1dtuqxw1m5iwhe - DIRECTOR_APPOINTED: John K. Jenkins, M.D. seat on Corbus Pharmaceuticals Holdings, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:1agm43v1mz4nez - DIRECTOR_APPOINTED: Yuval Cohen, Ph.D. seat on Corbus Pharmaceuticals Holdings, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-17T04:46:51.162298+00:00. event_id=alpha:event:transition:bx3cmela5zys ## Scoped resources - `alpha://company/corbus-pharmaceuticals-holdings-inc` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record - `alpha://company/corbus-pharmaceuticals-holdings-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=identity - `alpha://company/corbus-pharmaceuticals-holdings-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=corporate-structure - `alpha://company/corbus-pharmaceuticals-holdings-inc/board` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=board - `alpha://company/corbus-pharmaceuticals-holdings-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=committees - `alpha://company/corbus-pharmaceuticals-holdings-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=leadership - `alpha://company/corbus-pharmaceuticals-holdings-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=ownership - `alpha://company/corbus-pharmaceuticals-holdings-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=financials - `alpha://company/corbus-pharmaceuticals-holdings-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=capital-structure - `alpha://company/corbus-pharmaceuticals-holdings-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=compensation - `alpha://company/corbus-pharmaceuticals-holdings-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=governance - `alpha://company/corbus-pharmaceuticals-holdings-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=shareholder-governance - `alpha://company/corbus-pharmaceuticals-holdings-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=audit - `alpha://company/corbus-pharmaceuticals-holdings-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=legal - `alpha://company/corbus-pharmaceuticals-holdings-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=risk - `alpha://company/corbus-pharmaceuticals-holdings-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=cyber - `alpha://company/corbus-pharmaceuticals-holdings-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=ai-governance - `alpha://company/corbus-pharmaceuticals-holdings-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=agents - `alpha://company/corbus-pharmaceuticals-holdings-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=ecosystem - `alpha://company/corbus-pharmaceuticals-holdings-inc/events` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=events - `alpha://company/corbus-pharmaceuticals-holdings-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=relationships - `alpha://company/corbus-pharmaceuticals-holdings-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=assessments - `alpha://company/corbus-pharmaceuticals-holdings-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:winston-kung","name":"Winston Kung"},"source_id":"board_seats"}` - Claim alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:rachelle-s-jacques","name":"Rachelle S. Jacques"},"source_id":"board_seats"}` ## Leadership - Anne Altmeyer, Ph.D.: Director. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:5. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fec61f67bf0183ce3fffddd935c3f6768e08e319e386f3df8f7a6adec5cfdea8. - John K. Jenkins, M.D.: Director. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fec61f67bf0183ce3fffddd935c3f6768e08e319e386f3df8f7a6adec5cfdea8. - Rachelle S. Jacques: Director, Audit. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fec61f67bf0183ce3fffddd935c3f6768e08e319e386f3df8f7a6adec5cfdea8. - Winston Kung: Director, Audit · Chair. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fec61f67bf0183ce3fffddd935c3f6768e08e319e386f3df8f7a6adec5cfdea8. - Yuri Maricich, MD: Director. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fec61f67bf0183ce3fffddd935c3f6768e08e319e386f3df8f7a6adec5cfdea8. - Yuval Cohen, Ph.D.: Director. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:10. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fec61f67bf0183ce3fffddd935c3f6768e08e319e386f3df8f7a6adec5cfdea8. - Dominic Smethurst: Chief Medical Officer. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:11. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:446db7eb0cf7fe760bcbf55c79d068394bce9557540c3fc783af8591581d5795. - Ian Hodgson, Ph.D.: Chief Operating Officer. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:12. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3317f8724c491832c5607cb5af077f140c5d48cde6b7b3d716d7aae32eadb997. - Sean Moran: Chief Financial Officer. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:13. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8aa1ec8b0186a77327c3651c988e1b5ae1cefbd707889d42542bed40e2159ff1. - Yuval Cohen, Ph.D.: Chief Executive Officer, Director. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:leadership_role:14. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:138da31a17878fa450ecd26de69068909214be76ff4df450c022738531f0740c. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Winston Kung; Members Winston Kung (Chair); Rachelle S. Jacques. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7ab0d49ac3b68ef1156d195ca6e6d444a2a8db27af3b41e88b19da83a8050701. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Corbus Pharmaceuticals Holdings, Inc.. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:20748b432f8fa0d65b0a78b04b9b6bfac68f235cca30d127f793dc2945c871ef. ## Entity Status - Public listing published. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:20748b432f8fa0d65b0a78b04b9b6bfac68f235cca30d127f793dc2945c871ef. ## Published Fact - US. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:20748b432f8fa0d65b0a78b04b9b6bfac68f235cca30d127f793dc2945c871ef. ## Committee Appointment - Winston Kung: chair, Audit. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7ab0d49ac3b68ef1156d195ca6e6d444a2a8db27af3b41e88b19da83a8050701. - Rachelle S. Jacques: member, Audit. Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7ab0d49ac3b68ef1156d195ca6e6d444a2a8db27af3b41e88b19da83a8050701. ## Security Listing - CRBP (NASDAQ). Claim: alpha:claim:company:befc7502-fbe9-4f2c-9761-45d53d5c2a7d:security_listing:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:20748b432f8fa0d65b0a78b04b9b6bfac68f235cca30d127f793dc2945c871ef. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:20748b432f8fa0d65b0a78b04b9b6bfac68f235cca30d127f793dc2945c871ef: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc). - alpha:projection-evidence:document:fec61f67bf0183ce3fffddd935c3f6768e08e319e386f3df8f7a6adec5cfdea8: [Corbus Pharmaceuticals Holdings, Inc. DEF 14A 2026-04-02](https://www.sec.gov/Archives/edgar/data/1595097/000119312526140363/crbp-20260401.htm). - alpha:projection-evidence:document:446db7eb0cf7fe760bcbf55c79d068394bce9557540c3fc783af8591581d5795: [CRBP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm). - alpha:projection-evidence:document:3317f8724c491832c5607cb5af077f140c5d48cde6b7b3d716d7aae32eadb997: [CRBP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm). - alpha:projection-evidence:document:8aa1ec8b0186a77327c3651c988e1b5ae1cefbd707889d42542bed40e2159ff1: [CRBP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm). - alpha:projection-evidence:document:138da31a17878fa450ecd26de69068909214be76ff4df450c022738531f0740c: [CRBP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm). - alpha:projection-evidence:7ab0d49ac3b68ef1156d195ca6e6d444a2a8db27af3b41e88b19da83a8050701: [Audit](https://www.sec.gov/Archives/edgar/data/1595097/000119312526140363/crbp-20260401.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/corbus-pharmaceuticals-holdings-inc) - [Public Markdown](https://registry.alpha.ac/companies/corbus-pharmaceuticals-holdings-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/corbus-pharmaceuticals-holdings-inc?format=jsonld) - MCP resource: `alpha://companies/corbus-pharmaceuticals-holdings-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T15:33:02.048348+00:00; recorded 2026-10-17T15:33:02.048348+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.